Kotra Industries Bhd (0002) - Total Assets
Based on the latest financial reports, Kotra Industries Bhd (0002) holds total assets worth RM371.18 Million MYR (≈ $93.19 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Kotra Industries Bhd - Total Assets Trend (2005–2024)
This chart illustrates how Kotra Industries Bhd's total assets have evolved over time, based on quarterly financial data. Also see 0002 market cap for the company's overall valuation and market capitalisation.
Kotra Industries Bhd - Asset Composition Analysis
Current Asset Composition (December 2024)
Kotra Industries Bhd's total assets of RM371.18 Million consist of 39.5% current assets and 60.5% non-current assets. Review 0002 total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 9.2% |
| Accounts Receivable | RM35.23 Million | 10.1% |
| Inventory | RM51.76 Million | 14.9% |
| Property, Plant & Equipment | RM209.47 Million | 60.1% |
| Intangible Assets | RM0.00 | 0.0% |
| Goodwill | RM0.00 | 0.0% |
Asset Composition Trend (2005–2024)
This chart illustrates how Kotra Industries Bhd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 0002 stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kotra Industries Bhd's current assets represent 39.5% of total assets in 2024, a decrease from 62.2% in 2005.
- Cash Position: Cash and equivalents constituted 9.2% of total assets in 2024, down from 10.0% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is property, plant & equipment at 60.1% of total assets.
Kotra Industries Bhd Competitors by Total Assets
Key competitors of Kotra Industries Bhd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.84 Billion |
|
Neuland Laboratories Limited
NSE:NEULANDLAB
|
India | Rs29.30 Billion |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
|
China | CN¥6.49 Billion |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436
|
China | CN¥1.41 Billion |
Kotra Industries Bhd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.57 | 2.42 | 3.37 |
| Quick Ratio | 1.63 | 1.46 | 2.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RM82.16 Million | RM76.39 Million | RM90.10 Million |
Kotra Industries Bhd - Advanced Valuation Insights
This section examines the relationship between Kotra Industries Bhd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.92 |
| Latest Market Cap to Assets Ratio | 0.41 |
| Asset Growth Rate (YoY) | 2.8% |
| Total Assets | RM348.45 Million |
| Market Capitalization | $141.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kotra Industries Bhd's assets below their book value (0.41x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Kotra Industries Bhd's assets grew by 2.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Kotra Industries Bhd (2005–2024)
The table below shows the annual total assets of Kotra Industries Bhd from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | RM348.45 Million ≈ $87.49 Million |
+2.79% |
| 2023-12-31 | RM338.99 Million ≈ $85.11 Million |
+2.64% |
| 2022-12-31 | RM330.28 Million ≈ $82.92 Million |
+10.41% |
| 2021-12-31 | RM299.15 Million ≈ $75.11 Million |
+18.46% |
| 2020-12-31 | RM252.54 Million ≈ $63.41 Million |
-0.27% |
| 2019-12-31 | RM253.23 Million ≈ $63.58 Million |
+2.76% |
| 2018-12-31 | RM246.44 Million ≈ $61.87 Million |
+1.49% |
| 2017-12-31 | RM242.83 Million ≈ $60.97 Million |
-3.69% |
| 2016-12-31 | RM252.12 Million ≈ $63.30 Million |
-0.61% |
| 2015-12-31 | RM253.66 Million ≈ $63.69 Million |
-0.13% |
| 2014-12-31 | RM253.99 Million ≈ $63.77 Million |
-6.69% |
| 2013-12-31 | RM272.21 Million ≈ $68.34 Million |
+3.38% |
| 2012-12-31 | RM263.30 Million ≈ $66.11 Million |
+2.25% |
| 2011-12-31 | RM257.52 Million ≈ $64.65 Million |
+4.17% |
| 2010-12-31 | RM247.22 Million ≈ $62.07 Million |
+1.90% |
| 2009-12-31 | RM242.60 Million ≈ $60.91 Million |
+23.42% |
| 2008-12-31 | RM196.56 Million ≈ $49.35 Million |
+78.46% |
| 2007-12-31 | RM110.14 Million ≈ $27.65 Million |
+24.53% |
| 2006-12-31 | RM88.45 Million ≈ $22.21 Million |
+13.52% |
| 2005-12-31 | RM77.91 Million ≈ $19.56 Million |
-- |
About Kotra Industries Bhd
Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. The company provides nutraceutical products, including various health supplement products under the Appeton brand for children, expectant mothers, and senior citizens. It also offers various pharmaceutical products in the areas of pediatric care, anti-i… Read more